top of page

Equillium Announces Three Abstracts Accepted for Presentation at the 104th AAI Annual Meeting

Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab, and pharmacodynamic assays to monitor this in patients

Recent Posts

See All
bottom of page